The biological activity of monoclonal antibodies specific for the hemagglutinin protein of measles virus strain CAM recognizing six epitope groups according to their binding properties to measles virus strain CAM/R401 was investigated in vivo in our rat model of measles encephalitis. When injected intraperitoneally into measles virus-infected suckling rats, some monoclonal antibodies modified the disease process and prevented the necrotizing encephalopathy seen in untreated animals. The analysis of measles virus brain isolates revealed emergence of variants that resisted neutralization with the passively transferred selecting monoclonal antibody but not with other monoclonal antibodies. Monoclonal antibody escape mutants were also isolated in vitro, and their neurovirulence varied in the animal model. Sequence data from the hemagglutinin gene of measles virus localize a major antigenic surface determinant of the hemagglutinin protein between amino acid residues 368 and 396, which may be functionally important for neurovirulence. The data indicate that the interaction of antibodies with the measles virus H protein plays an important role in the selection of neurovirulent variants. These variants have biological properties different from those of the parent CAM virus.
The biological activity of monoclonal antibodies specific for the hemagglutinin protein of measles virus strain CAM recognizing six epitope groups according to their binding properties to measles virus strain CAM/R401 was investigated in vivo in our rat model of measles encephalitis. When injected intraperitoneally into measles virus-infected suckling rats, some monoclonal antibodies modified the disease process and prevented the necrotizing encephalopathy seen in untreated animals. The analysis of measles virus brain isolates revealed emergence of variants that resisted neutralization with the passively transferred selecting monoclonal antibody but not with other monoclonal antibodies. Monoclonal antibody escape mutants were also isolated in vitro, and their neurovirulence varied in the animal model. Sequence data from the hemagglutinin gene of measles virus localize a major antigenic surface determinant of the hemagglutinin protein between amino acid residues 368 and 396, which may be functionally important for neurovirulence. The data indicate that the interaction of antibodies with the measles virus H protein plays an important role in the selection of neurovirulent variants. These variants have biological properties different from those of the parent CAM virus.
Measles virus (MV) is an important human pathogen that leads to an acute infection which is still responsible for about 2 million deaths per year in developing countries. Besides acute measles, MV induces two fatal diseases of the central nervous system (CNS), subacute sclerosing panencephalitis (SSPE) and measles inclusion body encephalitis. These diseases develop as a result of persistent infections characterized by restriction of viral envelope gene expression as a consequence of transcriptional and translational alterations (27, 33) . SSPE develops in the presence of high-titered antimeasles antibodies in the cerebrospinal fluid and in serum which are apparently not able to eliminate MV in the brain. The extensive molecular sequencing of CNS-derived disease-associated MV genomes has demonstrated a surprisingly high frequence of nucleotide variations (4, 6, 31) , and it has become apparent that clonally distinct lineages of MV are present simultaneously in SSPE at the end stage of the long-lasting disease process (2) . Information on the biological significance of this observation for the course of infection, for disease development, and for its pathogenesis is lacking.
While much knowledge has been accumulated about the molecular organization of MV, its biological properties, in particular the molecular biology of its virulence and tropism, are not well understood. It has been shown in other virus-host systems that structural determinants on the major surface glycoprotein strongly influence viral tissue tropism and pathogenesis (22) . Therefore, to define the role of the hemagglutinin (H) protein for MV interaction with brain tissue, monoclonal antibodies (MAbs) against the H protein that neutralize the infectivity of MV were tested in our rat model of experimental measles infection. The biological effects of the MAbs on the selection of neurotropic variants and on the development of MV encephalomyelitis and the neutralization profiles of viral reisolates from brain material of infected and MAb-treated animals are described. The data obtained show a close correlation between in vivo-and in vitro-selected mutants. The results indicate that a selection of viral variants with neurovirulent properties occurs in infected animals in the presence of neutralizing MAbs. We also report the molecular characterization of a major antigenic site on the H protein and discuss its possible role in neurovirulence.
MATERIALS AND METHODS
Tissue culture, viruses, generation of MAbs, and serological tests. Conditions for growth of cells and the selection of MAbs have been reported previously (32) . Immunoglobulin (Ig) isotypes were determined by enzyme immunoassay (EIA) as instructed by the manufacturer (Medac, Hamburg, Germany). The CAM/R40 strain of MV, originally obtained from K. Yamanouchi, Tokyo, Japan (15) , was passaged by intracerebral (i.c.) inoculation in newborn Lewis rats. Stock CAM/RB virus (2 x 105 to 4 x 105 50% tissue culture infective doses per ml) was prepared as 25% brain homogenate from moribund rats in phosphate-buffered saline and used for all in vivo experiments because of the excellent reproducibility of disease course and duration as well as induced mortality (19) . For the selection of MAb escape mutants in vitro and the preparation of antigen, CAM/RB was passaged once on Vero cells (multiplicity of infection of 0.001). The titer of the resultant CAM/R401 was 8 x 106 to 15 x 106 PFU/ml.
MV antigen for serological assays was prepared by density gradient purification from infected Vero cells as described previously (17) . In the EIA, 1 pg of protein was coated onto flat-bottom microtiter plates and incubated with H-specific MAbs followed by phosphatase-coupled anti-mouse Ig and o-phenylenediamine as the substrate. Determination of hemagglutination-inhibiting (HI) activities, immunoprecipitation of in vivo-radiolabeled MV protein, sodium dodecyl sulfatepolyacrylamide gel electrophoresis, (SDS-PAGE), Western immunoblotting, and immunostaining were performed as described previously (3, 19, 23) . For the determination of MV neutralizing titers (NT titers), 100 PFU of virus was incubated
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(1 h at 37°C) with twofold dilutions of tissue culture supernatants containing MAbs against H protein. Then the virusantibody mixtures were incubated (1 h, 370C, 5% CO2) with semiconfluent monolayers of Vero cells, and monolayers were overlaid with 0.75% agar. The number of viral plaques was determined after 6 days following staining with neutral red. The NT titer of an antibody was determined as the dilution that neutralized more than 50% of the input virus (i.e., reduced the number of plaques to fewer than 50).
Competitive binding EIA. Mouse Ig of the MAbs was purified from hybridoma culture supernatant by either hydroxylapatite column purification or ammoni,jm sulfate precipitation. The purified Ig fractions (3 mg/ml) ziere coupled to biotin with biotinyl-N-hydroxylsuccinimide ester (BHSE; Pierce) as instructed by the distributor. Optimal self-competition by biotinylated antibodies was achieved with a BSHE/IgG ratio of 200 mg of BSHE per mg of IgG. For competition EIA, density gradient-purified CAM/R401 was coated onto roundbottom microtiter plates (Nunc) (1 [Lg of viral protein per well). The respective competitor antibody was applied in triplicate 10-fold dilutions and incubated for I h at 37°C.
Following extensive washes, the biotinylated Ig was added at a dilution that yielded an absorbance of 1.5 ± 0.2 (100% relative A492) as determined in a noncompetitive assay. After the final incubation with horseradish peroxidase coupled to avidin, o-phenylenediamine was used as the substrate. The criterion for overlapping antigen-binding sites (competition) was a reciprocal decrease of absorbance over several logs of antibody dilution. Each antibody was used both as a competitor as well as in the biotinylated form.
Isolation of viral escape mutants by using MAbs. For the isolation of MAb escape mutants, 10-fold dilutions (10' to 10-") of CAM/R401 were incubated with heat-inactivated (30 min at 56°C) virus-neutralizing H-specific ascites fluid (diluted 1:10; 45 min at 37°C) before infection of Vero cells. After 120 min, the virus-antibody dilution was removed and the infected cells were overlaid with 0.75% agar. Viral plaques were isolated after 5 to 6 days and seeded on 106 Vero cells in the presence of the respective anti-H ascites fluid (diluted 1:10). After two additional selection cycles, mutants remained stable in the absence of the respective antibody (i.e., they retained their property of being no longer neutralizable with the selecting antibody), and stocks were prepared and stored at -70°C for further use. Assessment of neurovirulence. Suckling (1-to 2-day-old) or weanling (3-to 4-week-old) Lewis rats, purchased from the Zentralinstitut fur Versuchstiere, Hannover, Germany, were infected by i.c. inoculation with CAM/RB (clarified supernatant, 104 PFU in 25 [L), with Vero cell-derived CAM/R401, or with MV escape variant CAM-L77, CAM-NC32, CAM-K29, or CAM-K71 (dose range, 0.5 x 106 to 1.6 x 106 PFU). In some experiments, suckling rats were injected intraperitoneally (i.p.), 4 to 8 h following i.c. infection, with 0.1 to 0.3 mg of Ig purified from hybridoma cultures equivalent to 5,000 MV neutralizing units (18) . Animals were observed for the occurrence of signs of encephalitis: hunched position, abnormal gait, ataxia, paresis, and convulsions. Some rats which did not induce overt disease were sacrificed for virological studies at 5 to 7 days (suckling) or 10 to 12 days (weanling rats) postinfection. Isolation of virus was attempted by cocultivation of the MV-permissive Vero cells with fresh brain material, and viral titers in CNS material were determined. Additionally, representative frozen brain sections were screened for the presence of viral antigen and neuropathological abnormalities as described previously (17) (18) (19) . Brain homogenate from newborn rats infected with mutant virus was used directly for infection of further litters. Three to four successive blind passages into newborn animals were done consecutively, after which we attempted to isolate virus from or demonstrate viral antigen in their brain tissues. This procedure was repeated before a mutant was considered nonneurovirulent.
cDNA cloning and nucleotide sequencing of escape mutant H genes. cDNA was produced by using synthetic oligonucleotide primers which were complementary in sequence to the 3' and 5' ends of MV H-gene mRNA (26) . First-strand cDNA-RNA hybrid molecules or double-stranded cDNA species were amplified in vitro by using Taq polymerase (Promega) for 30 3-min cycles of primer extension at 72°C in the presence of both forward and reverse H-gene primers (each at a final concentration of 10 ' M). The amplified reaction mixture was resolved by agarose gel electrophoresis, and the band of amplified MV H-gene cDNA was isolated on a DEAE membrane. The 5' termini of the DNA molecules were then phosphorylated with [y--3-P]ATP, and the 3' termini were digested (resected) with T4 DNA polymerase to regenerate the XmaI and Accl restriction site overhangs which had been engineered into the gene-specific oligonucleotide primers (26) . (11) with MV H-gene-specific random-primed DNA probes which had been labeled with [a-3_P]dCTP (9) . Colonies which were found to contain plasmids bearing full-length H-gene inserts or, in some cases, gene fragments were used for sequence analysis. MV H-gene sequences were determined by the dideoxynucleotide (chain termination) technique (25), using synthetic oligonucleotide primers (17-to 19-mers) corresponding to MV H-gene internal sequences in both strands. The primers were between 100 and 300 bp distant from each other and allowed overlapping sequences to be determined in both positive and negative strands of the H gene.
RESULTS
Characterization of MAbs by in vitro assays. All MAbs used in this study were generated against the Edmonston (EDM) strain of MV, were of either the IgG2a (K89, K17, NC26, NC32, K83, DW15, L77, and K4) or IgG3 (K29, K53, and K71) isotype, and, except for MAb K4, reacted also with CAM/ R401. The MAbs recognized conformational epitopes on the H protein, as they failed to bind in Western blots to MVinfected cell lysates. The specificity was proven by their ability to inhibit the hemagglutinating activity of MV (HI titer range of ascites fluid, 1:26 to 1:212) and to immunoprecipitate the in vivo-radiolabeled viral H protein, which appears as a broad band of approximately 75 to 80 kDa. All MAbs except K4 neutralized CAM/R401 in a plaque reduction assay (NT titers of 1:80 to 1:1,280 subacute measles encephalitis (SAME) that is observed in up to 20% of 3-week-old nontreated rats. Characteristics of in vivo-generated MAb variants. Infectious MV could be reisolated from rats that developed NE or AE. The titers of reisolates varied depending on the incubation period. In all animals tested before day 8 postinfection, levels of 104 to 104-5 PFU/g of brain weight were reached irrespective of antibody treatment. From recipients that developed AD-AE, viral titers isolated from CNS material were 1 to 3 orders of magnitude lower than titers from control rats, whereas no MV could be recovered from rats with AD-SAME ( Table 2) .
To further characterize the virus-host relationship in the presence of neutralizing antibodies, neutralization profiles of the viral reisolates from rats with AD-AE (n = 20) as well as nonmodulated encephalopathy (n = 13) were determined ( Isolation of MAb escape variants in vitro. To start with a defined population of cloned virus, escape variants were selected in vitro from MV CAM/R401, using the neutralizing H-specific MAbs. The variants were stable after three Vero cell passages in the presence of the respective selecting antibody. Mutant viral protein was prepared for EIA as well as HI tests to assess binding of MAbs other than those used for selection. In each case, the selecting MAbs and antibodies competing for the same epitope were no longer able to interact with the appropriate escape mutant, while the other MAbs were still binding, inhibited the hemagglutinating activity of mutant virus, and neutralized its infectivity. Thus the results of these tests correlated well with the competitive binding studies (Table 1) . Furthermore, immunoprecipitation experiments indicated that the selecting MAbs were incapable of precipitating the escape mutants in all cases. The virus stocks generated were used for infection of rats and for the generation of viral RNAs for cDNA cloning and sequence determination.
Neurovirulence of in vitro-isolated MAb escape variants. To determine whether their biological properties were different from those of the parent CAM/R401 virus, the neurovirulence of the escape mutants was assessed in the rat model for MV encephalitis. The results obtained with CAM/RB and CAM/ R401 were similar; also, escape variants CAM/L77 and CAM/ NC32 were highly neurovirulent and caused encephalitis with similar kinetics (Table 4 ). The virological and neuropathological properties were indistinguishable. The incidence of clinically overt encephalitis was lower in CAM/K83-infected rats, and infectious MV reisolated from brain material of these rats displayed the characteristics of the parent inoculum variant virus, as the reisolates remained resistant to neutralization by the selecting MAb but were neutralized by the other MAbs to a similar degree as the inoculating mutant (data not shown). The neurovirulence of mutant CAM/K17 was considerably lower, and both CAM/K29 and CAM/K71 were nonneurovirulent (Table 4) . Virus could not be reisolated 12 to 14 days after infection from rats treated with these MAbs.
To determine whether eventually neurotropic variants develop, consecutive blind passages through suckling rat brain of mutants CAM/K71 and CAM/K29 were done. The pattern and incidence of disease and viral titers isolated from clinically well animals at day 5 after infection did not change. No virus could be isolated from such rats 12 to 14 days after infection, thus providing no evidence for development of neurovirulent variants originating from either CAM/K71 or CAM/K29 (data not shown). On the other hand, reisolates from variant CAM/L77-, CAM/NC32-, or CAM/K83-infected rats were highly neurovirulent and remained stable in vivo.
Localization of mutations by nucleotide sequencing. To localize the mutations in the primary sequence of the H protein which were responsible for the abolition of MAb binding, the nucleotide sequences of the H genes of CAM/ R401 and the escape mutants were determined. The data indicate that of the 14 nucleotide changes between the published EDM strain sequence (1) and CAM, 12 are expressed. This might reflect the adaptation of the CAM strain to the rat brain. A nucleotide change from A to G at position 619 leads to loss of a glycosylation site in the CAM H protein. This site is used in EDM, as indicated by size difference of the CAM and EDM H proteins in SDS-PAGE (data not shown). Table 5 shows the differences between the CAM H-gene sequence and those of various MAb escape mutants. All the mutants share the mutations that lead to the regeneration of the glycosylation site at position 200 (S to N) and the change from G to R at position 195 in the amino acid sequence. In the escape mutant CAM/K29, these are the only changes observed between the mutant and the parent CAM virus. The three remaining mutants contained additional nucleotide sequence changes, which were located between nucleotides 1150 and 1203 and which affected amino acid residues 377 to 395 in the protein. In mutant CAM/L77, two expressed changes affecting consecutive amino acid residues were found. For each of the wild-type and escape mutant stocks, three to five clones were sequenced.
DISCUSSION
In this study, the in vitro and in vivo activities of a panel of MAbs reactive with the H protein of MV were determined. All MAbs recognize conformational epitopes and all except K4 neutralized the neuroadapted CAM in a complement-independent manner. Competitive binding ELAs revealed different profiles with partial competition between some of the antibodies, suggesting that six partially overlapping sites with seven epitopes are recognized by the MAbs on the H protein.
It is generally still accepted that the monotypic status of MV is biologically not changed by the existence of variants even DETERMINANTS FOR MEASLES VIRUS NEUROVIRULENCE (18, 28) . An inositol phospholipid signal generated by the binding of antibody to MV H protein was suggested to play a role in the down-regulation of viral antigens (35) . All of these factors may cooperate and result in modulation of disease course and pathology. Also in a clinical situation, variants that are particularly adapted to grow and survive in the CNS may be selected by the humoral immune response, leading to escape of some virus particles from immune surveillance. This interpretation is supported by the observation of an unbalanced primary immune response to individual epitopes on parainfluenza type 3 viral glycoproteins in reinfections of infants and children (7, 13) . (14) . They are also found as characteristic for MV and other paramyxovirus lineages and strains (8, 24, 34) and in MAb escape, such as in mumps virus (16) . It is possible that the presence of a carbohydrate side chain masks epitopes recognized by specific MAbs and changes the properties of a virus variant. In the case of the nonneurovirulent variant CAM/K29, the aforementioned sequence changes are the only ones found between the wild-type CAM strain and the escape mutant. In that sense, the mutations at positions 377, 378, and 388 observed in the CAM/L77 and CAM/NC32 escape variants appear to restore the neurovirulence characteristic of CAM. Double escape mutants will be used to study this question further and to rule out mutations outside the H gene as factors influencing the phenotype.
It is interesting that MAbs K71 and NC32 bind to partially overlapping epitopes, as observed in the competition binding assays. The escape mutations appear to be localized close, either C or N terminally, to cysteine 391, whereas the escape mutations for L77 MAb are further N terminal to this residue. This region of the H protein must represent a major antigenic site arranged on the surface so that different antibodies can bind to it in close proximity to each other without competition. Recently, mutations in this region have been found in escape mutants isolated with one of five H-reactive neutralizing MAbs, but nothing is known about their neurovirulence properties (12) .
As is the case with other viruses, analysis of the H-gene and protein sequences of various MV strains has not been able to highlight the presence of hypervariable regions that may reflect immune selection pressure. Comparative sequence analysis has provided an insight into conserved regions of the protein (8) , and when the H proteins of all paramyxoviruses and morbilliviruses are aligned and MAb escape mutations are localized on such an alignment, it becomes clear that the area between residues 368 and 396 in MV represents a part of the surface of the H molecule. Independently, it was proposed that a peptide sequence (residues 368 to 377) is localized on the surface because antipeptide sera have neutralizing activity (20) . However, neither the functional significance of this sequence nor the tertiary structure of paramyxovirus attachment proteins is known.
In summary, the neurovirulence of various neutralizing MAb escape mutants of the rodent-adapted CAM strain of MV has been correlated with specific protein changes, localized to a major antigenic surface determinant of the H protein of MV. It is likely that the changes in the H molecule of escape mutants induced by the selecting MAb are responsible for the biological properties of MV, including neurovirulence.
